|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Placental site trophoblastic tumor: analysis of presentation, treatment,and outcome显示文摘 | Hyman DM Bakios L Gualtiere G | 2013 | Gynecol Oncol2013，129，1： | 1 |
| 2 | Placental site trophoblastic tumor: analysis of presentation, treatment, and out- come 显示文摘 | HYMAN DM BAKIOS L GUALTIERE G | 2013 | Gynecol Onc012013，129，1： | 1 |
| 3 | Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease显示文摘 | Diamond EL Dagna L Hyman DM | 2014 | Blood2014，24，4： | 1 |
| 4 | Placental site trophoblastic tumor: analysis of presentation, treatment, and outcome显示文摘 | HYMAN DM BAKIOS L GUALTIERE G | 2013 | Gynecol Oncol2013，129，1： | 1 |
| 5 | Placental site tro- phoblastic tomor: analysis of presentation,treatment,and outcome显示文摘 | Hyman Dm Bakios L Guahiere G | 2013 | Gynecol Oncol2013，129，1： | 1 |
| 6 | Placental site trophoblastic tumor : analysis of presentation, treatment, and outcome显示文摘 | Hyman DM Bakios L Guahiere G | 2013 | Gynecol Oncol2013，129，： | 1 |
| 7 | Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations显示文摘 | Hyman DM Puzanov I Subbiah V | 2015 | N Engl J Med2015，373，8： | 1 |
| 8 | Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors显示文摘 | Hyman DM Snyder AE Carvajal RD | 2015 | Cancer Chemother Pharmaco12015，75，4： | 1 |
| 9 | Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCAl-associated serous ovarian cancer 显示文摘 | Hyman DM Zhou Q Iasonos A | 2012 | Cancer2012，118，15： | 1 |
| 10 | Endotoxin - in- duced changes in phospholipid dynamics of the stomach 显示文摘 | Dial E J Tran DM Hyman A Lichtenberger LM | 2013 | J Surg Res2013，180，1： | 1 |
| 11 | BRAF V600E mutation and Clonal Evolution in a patient with Relapsed Refractory Myeloma With Plasmablastic Differentiation显示文摘 | Bohn OL Hsu K Hyman DM | 2014 | Clin Lyphoma Myeloma Leuk2014，14，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员